There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Hillstream BioPharma to Attend the 12th Annual World Orphan Drug Congress USA on July 11-13.
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $1.03 and fluctuated between $1.1198 as its day high and $1.0200 as its day low. The current market capitalization of Hillstream BioPharma Inc. is $12.93M. A total of 0.1 million shares were traded on the day, compared to an average of 1.29M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, HILS has seen 13 BUY and 0 SELL insider trades, representing the acquisition of 4,501 and the disposition of 0 shares. Over the last 12 months, there were 63 BUYs and 0 SELLs from insiders. Insiders purchased 1,290,048 shares during that period but sold 0.
In the most recent transaction, MILBY RANDY bought 500 shares of HILS for 0.78 per share on Jun 17. After the transaction, the Chief Executive Officer now owns 2,937,940 company shares. In a previous transaction on Jun 06, MILBY RANDY bought 1,000 shares at 0.69 per share. HILS shares that Chief Executive Officer owns now total 2,938,540.
Among the insiders who bought shares, MILBY RANDY acquired of 1 shares on Jun 01 at a per-share price of $0.94. This resulted in the Chief Executive Officer holding 2,937,540 shares of HILS after the transaction. In another insider transaction, MILBY RANDY bought 1,000 shares at $0.79 per share on May 25. Company shares held by the Chief Executive Officer now total 2,937,539.
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for HILS in the last 3 months, the mean price target is $6.00 with high estimates of $6.00 and low estimates of $6.00. In terms of 52-week highs and lows, HILS has a high of $4.24 and a low of $0.65.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 1 analysts are providing their opinions on the stock. A total of 1 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.